NASDAQ:SILK

Silk Road Medical - SILK Stock Forecast, Price & News

$44.80

+0.51 (+1.15%)

(As of 08/18/2022 03:59 PM ET)

Add

Compare

Today's Range: $42.21
▼
$44.84
50-Day Range: $33.01
▼
$49.20
52-Week Range: $27.21
▼
$67.49

Volume: 13,371 shs
Average Volume: 341,436 shs
Market Capitalization: $1.58 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $49.33

Silk Road Medical MarketRank™ Forecast

Analyst Rating: Hold
2.40 Rating Score
Upside/Downside: 11.9% Upside
$49.33 Price Target
Short Interest: Bearish
6.57% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.74
Upright™ Environmental Score
News Sentiment: 0.25
Based on 8 Articles This Week
Insider Trading: Selling Shares
$4.70 M Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.81) to ($1.54) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

1021st out of 1,119 stocks

Surgical & Medical Instruments Industry

97th out of 111 stocks

2.2

Analyst's Opinion

Consensus Rating
Silk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $49.33, Silk Road Medical has a forecasted upside of 11.9% from its current price of $44.08.
Amount of Analyst Coverage
Silk Road Medical has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.57% of the float of Silk Road Medical has been sold short.
Short Interest Ratio / Days to Cover
Silk Road Medical has a short interest ratio ("days to cover") of 6.2.
Change versus previous month
Short interest in Silk Road Medical has recently increased by 15.03%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Silk Road Medical does not currently pay a dividend.
Dividend Growth
Silk Road Medical does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Silk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.
Environmental Sustainability
The Environmental Impact score for Silk Road Medical is -0.74.

2.4

News and Social Media Coverage

News Sentiment
Silk Road Medical has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 8 news articles for Silk Road Medical this week, compared to 1 article on an average week.
Search Interest
4 people have searched for SILK on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,698,350.00 in company stock.
Percentage Held by Insiders
Only 7.66% of the stock of Silk Road Medical is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Silk Road Medical are expected to grow in the coming year, from ($1.81) to ($1.54) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Silk Road Medical is -25.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Silk Road Medical is -25.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Silk Road Medical has a P/B Ratio of 25.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Silk Road Medical Stock Down 7.3 %

Shares of Silk Road Medical stock opened at $44.29 on Thursday. The business's 50 day simple moving average is $40.97 and its 200 day simple moving average is $37.51. Silk Road Medical has a 52-week low of $27.21 and a 52-week high of $67.49. The firm has a market cap of $1.56 billion, a PE ratio of -25.45 and a beta of 1.48. The company has a debt-to-equity ratio of 1.23, a quick ratio of 6.09 and a current ratio of 6.92.

Analyst Ratings Changes

A number of equities research analysts have recently commented on SILK shares. Stifel Nicolaus dropped their price target on Silk Road Medical from $55.00 to $46.00 in a research report on Monday, July 18th. Citigroup lowered Silk Road Medical from a "neutral" rating to a "sell" rating and set a $33.00 price target on the stock. in a research report on Monday, July 11th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Silk Road Medical has a consensus rating of "Hold" and a consensus target price of $49.33.

Insider Activity at Silk Road Medical

In related news, Director Elizabeth H. Weatherman sold 10,000 shares of Silk Road Medical stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $41.91, for a total value of $419,100.00. Following the sale, the director now owns 234,454 shares of the company's stock, valued at approximately $9,825,967.14. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Silk Road Medical news, CFO Lucas W. Buchanan sold 25,000 shares of the firm's stock in a transaction that occurred on Friday, August 12th. The stock was sold at an average price of $47.79, for a total value of $1,194,750.00. Following the completion of the transaction, the chief financial officer now directly owns 191,764 shares in the company, valued at $9,164,401.56. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Elizabeth H. Weatherman sold 10,000 shares of the firm's stock in a transaction that occurred on Friday, July 8th. The shares were sold at an average price of $41.91, for a total value of $419,100.00. Following the completion of the transaction, the director now owns 234,454 shares of the company's stock, valued at $9,825,967.14. The disclosure for this sale can be found here. In the last quarter, insiders have sold 105,000 shares of company stock valued at $4,698,350. 7.66% of the stock is owned by insiders.

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Stock News Headlines

August 2, 2022 | marketbeat.com

3 Small Caps With Big Return Potential (SILK)

In a year in which the risk-on trade has been muted, U.S. small cap stocks are holding up relatively well. In fact, the historically more volatile asset class is down approximately 13% year-to-date compared to 15% for U.S. large caps

August 15, 2022 | americanbankingnews.com

Insider Selling: Silk Road Medical, Inc (NASDAQ:SILK) CFO Sells 25,000 Shares of Stock

July 28, 2022 | nasdaq.com

SILK Crosses Above Average Analyst Target

July 27, 2022 | finance.yahoo.com

Silk Road Medical's Q2 Margins Hit By Manufacturing Expansion Costs

July 27, 2022 | americanbankingnews.com

Elizabeth H. Weatherman Sells 5,000 Shares of Silk Road Medical, Inc (NASDAQ:SILK) Stock

July 26, 2022 | seekingalpha.com

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q2 2022 Results - Earnings Call Transcript

July 25, 2022 | msn.com

Earnings Preview: Silk Road Medical

July 22, 2022 | finance.yahoo.com

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating

July 19, 2022 | seekingalpha.com

Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture

July 12, 2022 | finance.yahoo.com

Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022

July 12, 2022 | nasdaq.com

Silk Road Medical Breaks Above 200-Day Moving Average - Bullish for SILK

July 12, 2022 | finance.yahoo.com

Does Silk Road Medical (NASDAQ:SILK) Have A Healthy Balance Sheet?

June 15, 2022 | finance.yahoo.com

Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR

June 9, 2022 | finance.yahoo.com

Despite recent gains, Silk Road Medical, Inc (NASDAQ:SILK) insiders are still down US$8.9k after purchasing last year

June 2, 2022 | finance.yahoo.com

Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients

May 31, 2022 | finance.yahoo.com

Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing

May 17, 2022 | seekingalpha.com

Silk Road Medical, Inc 2022 Q1 - Results - Earnings Call Presentation

May 17, 2022 | markets.businessinsider.com

Analyst Ratings for Silk Road Medical

May 10, 2022 | finance.yahoo.com

Investors one-year losses grow to 41% as the stock sheds US$396m this past week

May 4, 2022 | finance.yahoo.com

Silk Road Medical Reports First Quarter 2022 Financial Results

May 3, 2022 | morningstar.com

Silk Road Medical Shares Surge on Expanded Enroute Approval

May 2, 2022 | marketwatch.com

Silk Road Medical Shares Surge on Expanded Enroute Approval >SILK

May 2, 2022 | seekingalpha.com

Silk Road Medical says FDA expanded approval for stent system

May 2, 2022 | finance.yahoo.com

Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System

April 26, 2022 | finance.yahoo.com

Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Company Calendar

Last Earnings: 11/09/2021
Today: 8/18/2022
Next Earnings (Estimated): 11/08/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SILK
CUSIP: N/A
CIK: 1397702
Web: www.silkroadmed.com
Phone: (408) 720-9002
Fax: 408-720-9013
Employees: 352
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $49.33
High Stock Price Forecast: $66.00
Low Stock Price Forecast: $33.00
Forecasted Upside/Downside: +10.1%
Consensus Rating: Hold
Rating Score (0-4): 2.40
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.74)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-49,810,000.00
Net Margins: -53.13%
Pretax Margin: -53.13%
Return on Equity: -82.20%
Return on Assets: -38.64%

Debt

Debt-to-Equity Ratio: 1.23
Current Ratio: 6.92
Quick Ratio: 6.09

Sales & Book Value

Annual Sales: $101.47 million
Price / Sales: 15.56
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.70 per share
Price / Book: 26.35

Miscellaneous

Outstanding Shares: 35,240,000
Free Float: 32,541,000
Market Cap: $1.58 billion
Optionable: Not Optionable
Beta: 1.48

Key Executives

Ms. Erica J. Rogers (Age 58)
Pres, CEO & Director
Comp: $987.28k
Mr. Lucas W. Buchanan (Age 45)
CFO & COO
Comp: $790.27k
Mr. Andrew S. Davis (Age 53)
Chief Commercial Officer
Comp: $777.22k
Mr. Richard M. Ruedy (Age 55)
Exec. VP of Clinical, Regulatory Affairs & Quality Assurance
Comp: $449.68k
Ms. Mhairi L. Jones
VP of Fin. & Accounting
Mr. Matthew McCarthy
VP of Marketing
Ms. Alison Highlander
VP of HR
Dr. Sumaira MacDonald
Exec. Medical Director
Dr. William Whealon Ph.D.
Exec. VP of R&D
Lynn Lewis
Investors Relations Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings or view top-rated stocks.
What is Silk Road Medical's stock price forecast for 2022?: 5 analysts have issued 1-year price objectives for Silk Road Medical's stock. Their SILK share price forecasts range from $33.00 to $66.00. On average, they anticipate the company's share price to reach $49.33 in the next twelve months. This suggests a possible upside of 11.4% from the stock's current price.
View analysts price targets for SILK or view top-rated stocks among Wall Street analysts.
How have SILK shares performed in 2022?: Silk Road Medical's stock was trading at $42.61 at the beginning of the year. Since then, SILK stock has increased by 3.9% and is now trading at $44.29.
View the best growth stocks for 2022 here.
When is Silk Road Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our SILK earnings forecast.
How were Silk Road Medical's earnings last quarter?: Silk Road Medical, Inc (NASDAQ:SILK) posted its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.09. The business earned $24.70 million during the quarter, compared to analysts' expectations of $26.03 million. Silk Road Medical had a negative net margin of 53.13% and a negative trailing twelve-month return on equity of 82.20%. During the same period in the prior year, the business earned ($0.31) EPS.
What guidance has Silk Road Medical issued on next quarter's earnings?: Silk Road Medical issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $128.00 million-$133.00 million, compared to the consensus revenue estimate of $129.32 million.

What other stocks do shareholders of Silk Road Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).
When did Silk Road Medical IPO?: (SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.
What is Silk Road Medical's stock symbol?: Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."
Who are Silk Road Medical's major shareholders?: Silk Road Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Deerfield Management Company L.P. Series C (7.60%), Clearbridge Investments LLC (4.37%), Kayne Anderson Rudnick Investment Management LLC (3.84%), TimesSquare Capital Management LLC (2.43%), State Street Corp (2.34%) and Ensign Peak Advisors Inc (1.35%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends.
How do I buy shares of Silk Road Medical?: Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Silk Road Medical's stock price today?: One share of SILK stock can currently be purchased for approximately $44.29.
How much money does Silk Road Medical make?: Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.56 billion and generates $101.47 million in revenue each year. The company earns $-49,810,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis.
How many employees does Silk Road Medical have?: The company employs 352 workers across the globe.
How can I contact Silk Road Medical?: Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 8/18/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Silk Road Medical - SILK Stock Forecast, Price & News

Silk Road Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability